ART352-L

ART352-L · Ankasa Regenerative Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ART352-L, covering 2020-10-12 to 2020-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion [Phase 1, Phase 2]